Type
|
Public |
---|---|
Traded as | NASDAQ: QSII S&P 600 Component |
Industry | Technology, Healthcare information services |
Founded | 1974 |
Headquarters | Irvine, California, United States |
Key people
|
Rusty Frantz (Chief Operating Officer) (Dec 31, 2013) |
Revenue | $ 440.76M (Dec 31, 2013) |
Number of employees
|
2,295 |
Website | www |
Rusty Frantz
(Chief Executive Officer, President and Director)
John K. Stumpf
(Interim Chief Financial Officer and Principal Accounting Officer)
Quality Systems, Inc.(NASDAQ:QSII) was set up on April 24, 1974 and is now based in Irvine, California, marketing on the healthcare information systems and connectivity solutions in the United States. There are four divisions operating in the company, namely QSI Dental, NextGen, Hospital Solutions, and Revenue Cycle Management (RCM) Services. Systems of the company can manage the patient information efficiently, which help the patients to redesign patient care and other workflow processes. On April 15, 2012, it acquired Matrix Management Solutions, LLC (Matrix). In September 2013, it acquired Mirth Corporation.
The QSI Dental division provides software suites (web-based), electronic data interchange (EDI) services for dental organizations to dental practices. The NextGen division provides solutions for ambulatory and dental organizations, including NextGen Ambulatory product suite, NextPen, and NextGen Community Connectivity products. The two divisions’ software could automate patient records in community health centers and hospital settings. The Hospital Solutions division provides financial management and billing software for rural and community hospitals, and revenue cycle management for the small and specialty hospital. This division also provides clinical offerings like clinical documentation and computerized physician order entry. The RCM Services division provides billing and collections, electronic claims submission and remittance, and expertise and support services.
In January 2014, NextGen Healthcare Information Systems announced that Ambulatory EHR version 5.8 solution had reached the ICD-10 standards. In March 2013, The company as an electronic health record provider, won the ONC-HIT 2014 Edition certification.
In January 2014, Inovalon, Inc. reached a multi-year agreement with NextGen to integrate Inovalon's data analytics with NextGen Share. After the integration, users could exchange clinical data and referrals without leaving their electronic health record system through the platform even without any onsite clinical resources.
In November, 2013, a class action was filed against the company, for issuing false and misleading press releases, financial statements during the Class Period.
2016-06-08 | Reiterated Rating | Jefferies Group | Hold | |
2016-06-08 | Reiterated Rating | Leerink Swann | Hold | |
2016-06-08 | Reiterated Rating | Morgan Stanley | Sell | |
2016-06-08 | Lower Price Target | Deutsche Bank | Sell | $13.00 to $12.00 |
2016-06-08 | Reiterated Rating | Oppenheimer | Hold | |
2016-06-08 | Lower Price Target | Deutsche Bank AG | Sell | $13.00 to $12.00 |
2016-06-08 | Reiterated Rating | Oppenheimer Holdings Inc. | Hold | |
2016-06-02 | Boost Price Target | SunTrust | Neutral | $12.00 to $13.00 |
2016-06-02 | Boost Price Target | SunTrust Banks Inc. | Neutral | $12.00 to $13.00 |
2016-05-23 | Reiterated Rating | Avondale Partners | Market Perform | $14.00 |
2016-05-22 | Reiterated Rating | FBR & Co. | Hold | |
2016-05-22 | Reiterated Rating | KeyBanc | Sell | |
2016-05-22 | Reiterated Rating | Deutsche Bank | Sell | |
2016-05-22 | Reiterated Rating | FBR & Co | Hold | |
2016-05-22 | Reiterated Rating | KeyCorp | Sell | |
2016-05-20 | Lower Price Target | Topeka Capital Markets | Buy | $18.00 to $17.00 |
2016-04-28 | Reiterated Rating | Oppenheimer | Hold | |
2016-03-16 | Boost Price Target | Leerink Swann | Market Perform | $15.00 to $16.00 |
2016-01-31 | Lower Price Target | Piper Jaffray | Overweight | $23.00 to $21.00 |
2016-01-31 | Reiterated Rating | Deutsche Bank | Sell | |
2016-01-31 | Lower Price Target | Piper Jaffray Cos. | Overweight | $23.00 to $21.00 |
2016-01-29 | Lower Price Target | Raymond James | Outperform | $21.00 to $19.00 |
2016-01-29 | Boost Price Target | Jefferies Group | Hold | $12.00 to $15.00 |
2016-01-29 | Lower Price Target | Evercore ISI | Hold | $16.00 to $15.00 |
2016-01-29 | Lower Price Target | RBC Capital | Sector Perform | $16.00 to $15.00 |
2016-01-29 | Lower Price Target | Raymond James Financial Inc. | Outperform | $21.00 to $19.00 |
2016-01-29 | Lower Price Target | Royal Bank Of Canada | Sector Perform | $16.00 to $15.00 |
2016-01-27 | Boost Price Target | Robert W. Baird | Neutral | $14.00 to $17.00 |
2016-01-25 | Upgrade | Jefferies Group | Neutral to Overweight | |
2016-01-25 | Upgrade | Piper Jaffray | Neutral to Overweight | $13.00 to $23.00 |
2016-01-07 | Boost Price Target | RBC Capital | Sector Perform | $14.00 to $16.00 |
2016-01-04 | Upgrade | Raymond James | Market Perform to Outperform | $21.00 |
2015-11-26 | Downgrade | Citigroup Inc. | Neutral to Sell | $26.00 |
2015-11-17 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $15.00 |
2015-11-03 | Lower Price Target | Cowen and Company | Market Perform | $17.00 to $15.00 |
2015-10-23 | Reiterated Rating | Leerink Swann | Hold | $14.00 to $15.00 |
2015-10-23 | Boost Price Target | Cowen and Company | Market Perform | $15.00 to $17.00 |
2015-10-21 | Initiated Coverage | Avondale Partners | Market Perform | $14.50 |
2015-10-16 | Initiated Coverage | Jefferies Group | Hold | |
2015-07-28 | Reiterated Rating | Leerink Swann | Hold | |
2015-07-27 | Lower Price Target | Leerink Swann | Market Perform | $17.00 to $14.00 |
2015-07-27 | Upgrade | RBC Capital | Underperform to Sector Perform | $14.00 |
2015-07-24 | Reiterated Rating | Topeka Capital Markets | Buy | $20.00 to $18.00 |
2015-07-23 | Lower Price Target | FBR & Co. | Market Perform | $17.00 to $14.00 |
2015-06-18 | Initiated Coverage | Stephens | Market Perform | |
2015-06-17 | Initiated Coverage | Oppenheimer | Market Perform | |
2015-06-11 | Lower Price Target | SunTrust | Neutral | $18.00 to $16.00 |
2015-06-09 | Reiterated Rating | Leerink Swann | Market Perform | $17.00 |
2015-06-09 | Lower Price Target | Topeka Capital Markets | Buy | $21.00 to $20.00 |
2015-05-29 | Reiterated Rating | Credit Suisse | Underperform | $17.00 to $18.00 |
2015-05-29 | Reiterated Rating | Credit Suisse Group AG | Underperform | $17.00 to $18.00 |
2015-05-24 | Reiterated Rating | Jefferies Group | Hold | $16.00 to $17.00 |
2015-03-18 | Downgrade | Robert W. Baird | Outperform to Neutral | $21.00 to $18.00 |
2015-03-09 | Downgrade | RBC Capital | Sector Perform to Underperform | $15.00 to $14.00 |
2015-01-26 | Reiterated Rating | Citigroup Inc. | Sell | $12.00 to $13.00 |
2015-01-22 | Upgrade | Evercore ISI | Sell to Hold | |
2014-11-20 | Downgrade | RBC Capital | Outperform to Sector Perform | $18.00 to $15.00 |
2014-08-06 | Reiterated Rating | Credit Suisse | Underperform | $17.00 to $15.00 |
2014-07-21 | Initiated Coverage | Topeka Capital Markets | Buy | $19.00 |
2014-06-02 | Reiterated Rating | Citigroup Inc. | Sell | $15.00 to $12.00 |
2014-05-30 | Reiterated Rating | Cowen and Company | Market Perform | $20.00 to $19.00 |
2014-05-30 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $18.00 to $15.00 |
2014-05-30 | Reiterated Rating | Credit Suisse | Underperform | $20.00 to $17.00 |
2014-05-30 | Reiterated Rating | Deutsche Bank | Sell | $15.00 to $12.00 |
2014-05-30 | Reiterated Rating | Jefferies Group | Hold | $20.00 to $17.50 |
2014-05-21 | Upgrade | RBC Capital | Sector Perform to Outperform | $19.00 |
2014-04-23 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $17.00 to $15.00 |
2014-04-15 | Reiterated Rating | Raymond James | Market Perform | |
2014-04-14 | Reiterated Rating | KeyBanc | Underweight | $14.00 |
2014-03-14 | Initiated Coverage | SunTrust | Neutral | $17.50 |
2014-03-07 | Upgrade | FBR & Co. | Underperform to Market Perform | $16.00 |
2014-02-18 | Initiated Coverage | Citigroup Inc. | Sell | |
2014-02-13 | Initiated Coverage | RBC Capital | Sector Perform | $19.00 |
2014-02-05 | Lower Price Target | KeyBanc | $19.00 to $16.00 | |
2014-01-24 | Lower Price Target | Oppenheimer | $26.00 to $24.00 | |
2014-01-24 | Lower Price Target | Jefferies Group | $23.00 to $20.00 | |
2014-01-13 | Reiterated Rating | B. Riley | Buy | $25.00 |
2013-11-20 | Initiated Coverage | Deutsche Bank | Sell | $17.50 |
2013-10-31 | Initiated Coverage | FBR & Co. | Underperform | $18.00 |
2013-10-25 | Boost Price Target | Robert W. Baird | Outperform | $26.00 to $28.00 |
2013-10-25 | Boost Price Target | Jefferies Group | Hold | $20.00 to $23.00 |
2013-10-04 | Boost Price Target | Oppenheimer | Outperform | $26.00 |
2013-10-03 | Boost Price Target | B. Riley | Buy | $27.00 |
2013-07-29 | Upgrade | Sterne Agee | Neutral to Buy | |
2012-08-23 | Reiterated | ISI Group | Hold | $17 to $19.50 |
2012-07-27 | Upgrade | Oppenheimer | Perform to Outperform | $20 |
2012-07-12 | Initiated | Standpoint Research | Accumulate | $31 |
2012-05-15 | Upgrade | Auriga | Hold to Buy | $42 to $37 |
2012-05-11 | Reiterated | Maxim Group | Buy | $50 to $45 |
2011-07-28 | Reiterated | Auriga | Hold | $81 to $87 |
2016-06-08 | Reiterated Rating | Jefferies Group | Hold | |
2016-06-08 | Reiterated Rating | Leerink Swann | Hold | |
2016-06-08 | Reiterated Rating | Morgan Stanley | Sell | |
2016-06-08 | Lower Price Target | Deutsche Bank | Sell | $13.00 to $12.00 |
2016-06-08 | Reiterated Rating | Oppenheimer | Hold |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In QSII 19 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 3.86M |
BlackRock Institutional Trust Company, N.A. | 1.18M |
RUSSELL FRANK CO/ | 0.30M |
BlackRock Investment Management, LLC | 0.25M |
MANAGED ACCOUNT ADVISORS LLC | 0.15M |
BlackRock Group LTD | 0.12M |
CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 64575 |
BAIRD ROBERT W & CO INC /WI/ | 63430 |
PEAK6 Investments, L.P. | 53892 |
Spot Trading L.L.C | 43300 |
BLACKROCK ADVISORS LLC | 26424 |
Airain ltd | 22131 |
VTL Associates, LLC | 18537 |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 16800 |
Dynamic Technology Lab Pte Ltd | 10532 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
RAZIN SHELDON | 17.00% (10237374) | QSII / |
HUSSEIN AHMED D | 9.44% (5687696) | QSII / |
Arnold James Robert Jr. Chief Financial Officer | 0.35% (212156) | QSII / |
Frantz John R CEO and President | 0.19% (111844) | QSII / |
MARGOLIS JEFFREY H | 0.11% (63457) | CROX / QSII / |
Barbarosh Craig A. | 0.10% (62593) | BV / QSII / SBRA / |
Bristol George H | 0.09% (55847) | QSII / |
Bostick Scott E Chief Operating Officer | 0.08% (46813) | QSII / |
Metcalfe David A Chief Technology Officer | 0.08% (46813) | QSII / |
Rosenzweig Lance | 0.07% (43046) | QSII / WIFI / |
MALONE JAMES C | 0.07% (40603) | QSII / |
PANNER MORRIS | 0.06% (39128) | QSII / |
Pflueger Russell | 0.05% (29177) | QSII / |
MOREFIELD DANIEL EVP, Chief Operating Officer | 0.04% (21859) | QSII / |
Leavitt Jocelyn EVP, General Counsel/Secretary | 0.03% (17091) | QSII / |
STUMPF JOHN K Interim Chief FinancialOfficer | 0.02% (14887) | CLGX / QSII / |
Plochocki Steven T Chief Executive Officer | 0.02% (11122) | QSII / |
HOLT PAUL Chief Financial Officer | 0.02% (9950) | NH / QSII / |
Klapstein Julie D | 0.02% (9189) | AMED / QSII / SR / |
Decker Scott D President, NextGen Healthcare | 0.01% (9000) | QSII / |
Neufeld Donn EVP EDI and Dental | 0.01% (8864) | QSII / |
Brennan Murray F | 0.01% (8000) | QSII / |
SANDLER MONTE EVP NextGen RCM Services | 0.01% (5900) | QSII / |
NEUPERT PETER M | 0.01% (5836) | LH / QSII / |
Puckett Steve EVP Hospital Solutions | 0.01% (5794) | QSII / |
SPIVACK MAUREEN | 0.01% (5000) | QSII / |
DAVIS MARK H | 0.01% (3664) | QSII / |